{
    "clinical_study": {
        "@rank": "27008", 
        "brief_summary": {
            "textblock": "The purpose of this clinical research study is to learn if BMS-247550 can shrink or slow the\n      growth of the cancer in patients with non-small cell lung cancer who have failed first-line\n      platinum based chemotherapy.  The safety of this treatment will also be studied."
        }, 
        "brief_title": "A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy", 
        "completion_date": {
            "#text": "April 2004", 
            "@type": "Actual"
        }, 
        "condition": "Carcinoma, Non-small-cell Lung", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Non-Small-Cell Lung"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically or cytologically confirmed non-small cell lung cancer\n\n          -  Bidimensionally measurable disease\n\n          -  Progressed following therapy with one prior cisplatin or carboplatin based\n             chemotherapy regimen for Stage III or IV or metastatic recurrent disease\n\n          -  Adequate hematologic function as defined by: absolute neutrophils =/> 2,000/mm3, and\n             platelets > 125,000/mm3\n\n          -  Adequate hepatic function as defined by: serum bilirubin=/<1.5 times the upper\n             institutional limits of normal, ALT =/< 2.5 times the upper institutional limits of\n             normal (=/<5 times the upper institutional limits of normal if hepatic metastases are\n             present\n\n          -  Adequate renal function as defined: by serum creatine =/< 1.5 times the upper limits\n             of normal\n\n          -  Adequate recovery from recent surgery, chemotherapy and radiation therapy. At least\n             one week must have elapsed from the time of a minor surgery, at least 3 weeks for\n             major surgery, chemotherapy and radiation therapy\n\n          -  Life expectancy of at least 12 weeks\n\n          -  ECOG performance status of 0-1\n\n          -  At least 18 years old\n\n          -  Willing and able to give written informed consent\n\n          -  Accessible for treatment and follow-up.  Patients enrolled in this trial must be\n             treated at the participating center\n\n          -  Women of Child Bearing Potential (WOCP) must have a negative serum or urine pregnancy\n             test (minimum sensitivity IU/L or equivalent units of HCG) within 72 hours prior to\n             start of study medication.\n\n        WOCBP include any female who has experienced menarche and who has not undergone successful\n        surgical sterilization (hysterectomy, bilateral tubal ligation or bilateral oophorectomy)\n        or is not postmenopausal [defined as amenorrhea=/>12 consecutive months; or women on\n        hormone replacement therapy (HRT) with documented serum follicle stimulating hormone (FSH)\n        level > 35mIU/mL]. Even women who are using oral, implanted or, injectable intrauterine\n        device or barrier methods (diaphragm, condoms, spermicide) to prevent pregnancy or\n        practicing abstinence or where partner is sterile (e.g., vasectomy), should be considered\n        to be of child bearing potential.\n\n        Exclusion Criteria\n\n          -  More than one prior chemotherapy regimen for Stage IIIB or IV or for metastatic\n             recurrent disease.  Prior adjuvant or neoadjuvant chemotherapy is allowed.\n\n          -  Patients who are candidates for curative resection.\n\n          -  CTC Grade 2 or greater neuropathy (motor or sensory)\n\n          -  Known brain metastases\n\n          -  Prior radiation must have not included major bone marrow containing areas (pelvis,\n             lumbar, spine) and must not have contained a target lesion as the only measurable\n             lesion.  A recovery period of at least 3 weeks after completion of radiotherapy is\n             required prior to enrollment.\n\n          -  Myocardial infarction, unstable angina, or any history of congestive heart failure\n             within six months of study therapy\n\n          -  Pregnant or breast-feeding women, or sexually active women of childbearing potential\n             not using an adequate method of birth control.\n\n          -  Sexually active fertile men, whose partners are women of childbearing potential,\n             unless using an adequate method of birth control\n\n          -  Serious intercurrent infections, or nonmalignant medical illnesses that are\n             controlled or whose control may be jeopardized by the complications of this therapy\n\n          -  Psychiatric disorders or other conditions rendering the patient incapable of\n             complying with the requirements of the the protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "May 3, 2002", 
        "id_info": {
            "nct_id": "NCT00035516", 
            "org_study_id": "CA163-011"
        }, 
        "intervention": {
            "intervention_name": "Epothilone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Epothilones"
        }, 
        "lastchanged_date": "April 7, 2011", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "University of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "958177"
                    }, 
                    "name": "Un of California Davis Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33140"
                    }, 
                    "name": "Mount Sinai Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "H Lee Moffitt Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612-3828"
                    }, 
                    "name": "Rush Presbyterian St Lukes ME"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40207"
                    }, 
                    "name": "Consultants in Blood Disorders"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70121"
                    }, 
                    "name": "Ochsner Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21201"
                    }, 
                    "name": "University of Maryland Greenbaum Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Burlington", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01805"
                    }, 
                    "name": "Lahey Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65203"
                    }, 
                    "name": "University of Missouri/Ellis Fischel Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lebanon", 
                        "country": "United States", 
                        "state": "New Hampshire", 
                        "zip": "03756"
                    }, 
                    "name": "Dartmouth-Hitchcock /Norris Cotton Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Brunswick", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08901"
                    }, 
                    "name": "Cancer Institute of New Jersey"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599"
                    }, 
                    "name": "Unviversity of North Carolina"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232-5536"
                    }, 
                    "name": "Vanderbilt University Med School Div of Medical Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37203"
                    }, 
                    "name": "Sarah Cannon Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53792"
                    }, 
                    "name": "University of Wisconsin Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2004", 
            "@type": "Actual"
        }, 
        "reference": {
            "PMID": "17606973", 
            "citation": "Vansteenkiste J, Lara PN Jr, Le Chevalier T, Breton JL, Bonomi P, Sandler AB, Socinski MA, Delbaldo C, McHenry B, Lebwohl D, Peck R, Edelman MJ. Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy. J Clin Oncol. 2007 Aug 10;25(23):3448-55. Epub 2007 Jul 2. Erratum in: J Clin Oncol. 2007 Nov 20;25(33):5339. Edelman, Mark [corrected to Edelman, Martin J]."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00035516"
        }, 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2001", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2011"
    }, 
    "geocoordinates": {
        "Cancer Institute of New Jersey": "40.486 -74.452", 
        "Consultants in Blood Disorders": "38.253 -85.758", 
        "Dartmouth-Hitchcock /Norris Cotton Cancer Center": "43.642 -72.252", 
        "H Lee Moffitt Cancer Center": "27.951 -82.457", 
        "Lahey Clinic": "42.505 -71.196", 
        "Mount Sinai Medical Center": "25.791 -80.13", 
        "Ochsner Cancer Institute": "29.951 -90.072", 
        "Rush Presbyterian St Lukes ME": "41.878 -87.63", 
        "Sarah Cannon Cancer Center": "36.166 -86.784", 
        "Un of California Davis Cancer Center": "38.582 -121.494", 
        "University of Alabama at Birmingham": "33.521 -86.802", 
        "University of Maryland Greenbaum Cancer Center": "39.29 -76.612", 
        "University of Missouri/Ellis Fischel Cancer Center": "38.952 -92.334", 
        "University of Wisconsin Hospital": "43.073 -89.401", 
        "Unviversity of North Carolina": "35.913 -79.056", 
        "Vanderbilt University Med School Div of Medical Oncology": "36.166 -86.784"
    }
}